Neutrophil-To-Lymphocyte Ratio Predicts 3-Month Outcome of Acute Ischemic Stroke

Neurotoxicity Research

Volumn 31, Issue 3, 2017, Pages 444-452

  Qun, Sen ^a,b   Tang, Yan ^a   Sun, Jing ^a   Liu, Zhaoxia ^a   Wu, Juncang ^b   Zhang, Ji ^b   Guo, Jidong ^c   Xu, Zhiqiang ^a   Zhang, Dan ^a   Chen, Zhengxu ^b   Hu, Fuyong ^b   Xu, Xingshun ^a,d   Ge, Wei ^a,e  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c THE AFFILIATED GUANGJI HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d SOOCHOW UNIVERSITY   (China)

^e XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

3 month outcome; Acute ischemic stroke; Neutrophil to lymphocyte ratio; Patients

Indexed keywords

TRIACYLGLYCEROL;

AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTIVE VALUE; PROGNOSIS; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; BLOOD; LYMPHOCYTE; NEUTROPHIL; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STROKE;

AGED; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHOCYTES; MALE; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 85011844983     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-017-9707-z     Document Type: Article

References (50)

1. Azab B et al (2010) Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 106:470–476. doi:10.1016/j.amjcard.2010.03.062
2. Banks JL, Marotta CA (2007) Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke: a journal of cerebral circulation 38:1091–1096. doi:10.1161/01.STR.0000258355.23810.c6
3. Barone FC et al (1991) Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res 29:336–345. doi:10.1002/jnr.490290309
4. Bowes MP, Rothlein R, Fagan SC, Zivin JA (1995) Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 45:815–819
5. Brooks SD et al (2014) Admission neutrophil-lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy. J Neurointerv Surg 6:578–583. doi:10.1136/neurintsurg-2013-010780
6. Buck BH et al (2008) Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke; a journal of cerebral circulation 39:355–360. doi:10.1161/STROKEAHA.107.490128
7. Buratti L et al (2014) Blood pressure variability and stroke outcome in patients with internal carotid artery occlusion. J Neurol Sci 339:164–168. doi:10.1016/j.jns.2014.02.007
8. Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Davalos A (2003) Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke; a journal of cerebral circulation 34:40–46
9. Celikbilek A, Ismailogullari S, Zararsiz G (2014) Neutrophil to lymphocyte ratio predicts poor prognosis in ischemic cerebrovascular disease. J Clin Lab Anal 28:27–31. doi:10.1002/jcla.21639
10. Chopp M, Li Y, Jiang N, Zhang RL, Prostak J (1996) Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 16:578–584. doi:10.1097/00004647-199607000-00007
11. Clark WM, Lauten JD, Lessov N, Woodward W, Coull BM (1995) The influence of antiadhesion therapies on leukocyte subset accumulation in central nervous system ischemia in rats. Journal of molecular neuroscience: MN 6:43–50. doi:10.1007/bf02736758
12. Connolly ES Jr et al (1996) Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 97:209–216. doi:10.1172/jci118392
13. Davies CA, Loddick SA, Stroemer RP, Hunt J, Rothwell NJ (1998) An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat. Exp Neurol 154:199–212. doi:10.1006/exnr.1998.6891
14. Demir R, Ulvi H, Ozel L, Ozdemir G, Guzelcik M, Aygul R (2012) Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke. Acta Neurol Belg 112:351–356. doi:10.1007/s13760-012-0067-4
15. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL (2006) Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97:993–996. doi:10.1016/j.amjcard.2005.10.034
16. Fiorelli M et al (1999) Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European cooperative acute stroke study I (ECASS I) cohort. Stroke; a journal of cerebral circulation 30:2280–2284
17. Fu Y, Liu Q, Anrather J, Shi FD (2015) Immune interventions in stroke. Nat Rev Neurol 11:524–535. doi:10.1038/nrneurol.2015.144
18. Garau A et al (2005) Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia. Cytokine 30:125–131. doi:10.1016/j.cyto.2004.12.014
19. Gary T et al (2013) Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients. PLoS One 8:e56745. doi:10.1371/journal.pone.0056745
20. Gautier S, Ouk T, Petrault O, Caron J, Bordet R (2009) Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia. Br J Pharmacol 156:673–679. doi:10.1111/j.1476-5381.2009.00068.x
21. Gibson PH et al (2007) Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 154:995–1002. doi:10.1016/j.ahj.2007.06.043
22. Gibson PH et al (2010) Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 105:186–191. doi:10.1016/j.amjcard.2009.09.007
23. Gokhan S, Ozhasenekler A, Mansur Durgun H, Akil E, Ustundag M, Orak M (2013) Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack. Eur Rev Med Pharmacol Sci 17:653–657
24. Herz J, Sabellek P, Lane TE, Gunzer M, Hermann DM, Doeppner TR (2015) Role of neutrophils in exacerbation of brain injury after focal cerebral ischemia in hyperlipidemic mice. Stroke; a journal of cerebral circulation 46:2916–2925. doi:10.1161/STROKEAHA.115.010620
25. Horne BD et al (2005) Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45:1638–1643. doi:10.1016/j.jacc.2005.02.054
26. Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66:232–245. doi:10.1016/j.surneu.2005.12.028
27. Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR (2015) Targeting neutrophils in ischemic stroke: translational insights from experimental studies. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 35:888–901. doi:10.1038/jcbfm.2015.45
28. Kim JY, Park J, Chang JY, Kim SH, Lee JE (2016) Inflammation after ischemic stroke: the role of leukocytes and glial cells. Exp Neurobiol 25:241–251. doi:10.5607/en.2016.25.5.241
29. Klehmet J et al (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158:1184–1193. doi:10.1016/j.neuroscience.2008.07.044
30. Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7:97. doi:10.1186/1479-5876-7-97
31. Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M (2015) Blood pressure variability and clinical outcome in patients with acute intracerebral hemorrhage. J Stroke Cerebrovasc Dis 24:1493–1499. doi:10.1016/j.jstrokecerebrovasdis.2015.03.014
32. Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M (2016) Neutrophil-to-lymphocyte ratio predicts the outcome of acute intracerebral hemorrhage. Stroke; a journal of cerebral circulation 47:1654–1657. doi:10.1161/STROKEAHA.116.013627
33. Liesz A et al (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15:192–199. doi:10.1038/nm.1927
34. Liesz A et al (2013) Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. The Journal of neuroscience: the official journal of the Society for Neuroscience 33:17350–17362. doi:10.1523/JNEUROSCI.4901-12.2013
35. Lyden P et al (1994) Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 25:2220--2226
36. Matsuo Y, Kihara T, Ikeda M, Ninomiya M, Onodera H, Kogure K (1995) Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 15:941–947. doi:10.1038/jcbfm.1995.119
37. Montaner J et al (2001) Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke; a journal of cerebral circulation 32:1759–1766
38. Montaner J et al (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107:598–603
39. Muhmmed Suliman MA, Bahnacy Juma AA, Ali Almadhani AA, Pathare AV, Alkindi SS, Uwe Werner F (2010) Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res 41:618–622. doi:10.1016/j.arcmed.2010.11.006
40. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F (2008) Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clinica chimica acta; international journal of clinical chemistry 395:27–31. doi:10.1016/j.cca.2008.04.019
41. Petrault O, Ouk T, Gautier S, Laprais M, Gele P, Bastide M, Bordet R (2005) Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion. Br J Pharmacol 144:1051–1058. doi:10.1038/sj.bjp.0706124
42. Posada-Duque RA, Barreto GE, Cardona-Gomez GP (2014) Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci 8:231. doi:10.3389/fncel.2014.00231
43. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, Offner H (2011) Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. The Journal of neuroscience: the official journal of the Society for Neuroscience 31:8556–8563. doi:10.1523/JNEUROSCI.1623-11.2011
44. Satoh S et al (1999) Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction. Jpn J Pharmacol 80:41–48
45. Schroeter M, Jander S, Witte OW, Stoll G (1994) Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol 55:195–203
46. Tokgoz S, Kayrak M, Akpinar Z, Seyithanoglu A, Guney F, Yuruten B (2013) Neutrophil lymphocyte ratio as a predictor of stroke. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association 22:1169–1174. doi:10.1016/j.jstrokecerebrovasdis.2013.01.011
47. Tokgoz S, Keskin S, Kayrak M, Seyithanoglu A, Ogmegul A (2014) Is neutrophil/lymphocyte ratio predict to short-term mortality in acute cerebral infarct independently from infarct volume? J Stroke Cerebrovasc Dis 23:2163–2168. doi:10.1016/j.jstrokecerebrovasdis.2014.04.007
48. Yenari MA et al (1998) Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia. Exp Neurol 153:223–233. doi:10.1006/exnr.1998.6876
49. Zahorec R (2001) Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratislavske lekarske listy 102:5–14
50. Zhang RL, Chopp M, Chen H, Garcia JH (1994) Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J Neurol Sci 125:3–10